Naloxone-like actions of MIF-1 do not require the presence of the pituitary
- 1 December 1980
- journal article
- research article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 13 (6) , 907-912
- https://doi.org/10.1016/0091-3057(80)90227-0
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Interaction of MIF-I or alpha-MSH with D-amphetamine or chlorpromazine on thermoregulation and motor activity of rats maintained at different ambient temperaturesPeptides, 1980
- Development of narcotic tolerance and physical dependence: Effects of Pro-Leu-Gly-NH2 and cyclo (Leu-Gly)Pharmacology Biochemistry and Behavior, 1980
- MIF-I's differential actions as an opiate antagonistPharmacology Biochemistry and Behavior, 1979
- CNS effects of peripherally administered brain peptidesLife Sciences, 1979
- Attenuation of morphine tolerance and dependence by α-melanocyte stimulating hormone (α-MSH)Life Sciences, 1979
- Potentiation of the inhibitory effect of 5-hydroxytryptophan on the righting reflex in the frog as a sensitive test for antidepressantsJournal of Pharmacological Methods, 1979
- Naloxone effects on a nociceptive response of hypophysectomized and adrenalectomized miceLife Sciences, 1978
- Effects of various amino acids and their related agents in association with neurotransmitter substances on the morphine-induced Straub tail reaction in mice.CHEMICAL & PHARMACEUTICAL BULLETIN, 1978
- Prolyl-leucyl-glycinamide (PLG) facilitates morphine dependenceLife Sciences, 1976
- DOPA Potentiation by a hypothalamic factor, MSH release-inhibiting hormone (MIF)Life Sciences, 1971